MALAT1 and Parkinson disease: In an MPTP-induced PD model, MALAT1 recruits the enhancer of zeste homolog 2 (EZH2) to the nuclear factor-like-2 (NRF2) promoter and inhibits NRF2 expression, thereby facilitating inflammasome activation in PD microglia and mouse models [58].